Banerjee, Sulagna <br/><br/>
CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  May 2014 
 - 2388-99 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-2947  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Animals<br/>Antigens, CD--genetics<br/>Antigens, Surface--metabolism<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--genetics<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cell Transformation, Neoplastic--genetics<br/>Disease Models, Animal<br/>Diterpenes<br/>Epoxy Compounds<br/>Gene Expression<br/>Glycoproteins--genetics<br/>Immunophenotyping<br/>Mice<br/>Mice, Transgenic<br/>NF-kappa B--metabolism<br/>Neoplastic Stem Cells--drug effects<br/>Organophosphates--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Peptides--genetics<br/>Phenanthrenes--administration & dosage<br/>Phenotype